Dr Lennard Lee

Lennard is a force of nature in medical research - driven, tenacious, and deeply committed to transforming lives. Since 2020, he has led groundbreaking national programmes, uniting scientists, clinicians, and policymakers to advance healthcare in bold new ways.

At EIT, he leads the Medical Department with a clear mission: delivering safer, faster, and more effective care. His team builds world-class infrastructure, forges game-changing partnerships, and pioneers discoveries that set new standards in medicine.

A national leader in cancer vaccines, Lennard is shaping the future of cancer treatment. He co-founded the NHS Cancer Vaccine Launchpad, and is leading on a national advance, accelerating trials and enrolling 10,000patients by 2030. His work ensures that the latest breakthroughs reach patients swiftly, bridging cutting-edge science with real-world impact.

His dedication has earned him top honours, including the ACP McElwain Prize, IAP Outstanding Young Physicians Award, DSIT Superhero Award, and UK Science & Engineering Infinity Award. With 50+ publications and widespread media coverage, his influence extends across research, policy, and patient care.

Lennard thrives on collaboration—bringing together academia, industry, government, and health systems to turn vision into reality. He has led national-scale initiatives like the UK COVID Cancer Programme, the rapid rollout of lateral flow testing, and the record-breaking NHS-Galleri trial, enrolling 140,000 patients in just 10.2 months.

His leadership drives innovation with real impact, inspiring teams to push boundaries, accelerate progress, and shape a new model of healthcare and the future medicine.